2 results
Approved WMOWill not start
To assess the safety and tolerability profile of durvalumab monotherapy, durvalumab + novel oncology therapy, durvalumab + chemotherapy, anddurvalumab + novel oncology therapy + chemotherapy combinations
Approved WMORecruiting
The primary objective of this study is to demonstrate the clinically applicable use of robotic-assistance in lower extremity free-flap reconstruction.